Percutaneous radiofrequency ablation in the treatment of pulmonary malignancies: efficacy, safety and predictive factors.
Streitparth T, Schumacher D, Damm R, Friebe B, Mohnike K, Kosiek O, Pech M, Ricke J, Streitparth F.
Oncotarget. 2018 Jan 18;9(14):11722-11733. doi: 10.18632/oncotarget.24270. eCollection 2018 Feb 20.
PMID:29545932
Percutaneous radiofrequency ablation of pulmonary tumors--is there a difference between treatment under general anaesthesia and under conscious sedation?
Hoffmann RT, Jakobs TF, Lubienski A, Schrader A, Trumm C, Reiser MF, Helmberger TK.